Victory Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-50,555
Closed -$44.8K 2740
2022
Q4
$44.8K Sell
50,555
-230,802
-82% -$306K ﹤0.01% 2463
2022
Q3
$442K Buy
281,357
+162,123
+136% +$368K ﹤0.01% 2100
2022
Q2
$240K Sell
119,234
-141,128
-54% -$244K ﹤0.01% 2295
2022
Q1
$393K Buy
260,362
+223,602
+608% +$697K ﹤0.01% 2215
2021
Q4
$171K Buy
36,760
+2,524
+7% +$15.7K ﹤0.01% 2511
2021
Q3
$261K Sell
34,236
-16,234
-32% -$138K ﹤0.01% 2430
2021
Q2
$489K Buy
50,470
+2,398
+5% +$19.1K ﹤0.01% 2222
2021
Q1
$398K Buy
48,072
+962
+2% +$10.2K ﹤0.01% 2303
2020
Q4
$322K Buy
47,110
+29,729
+171% +$239K ﹤0.01% 2262
2020
Q3
$194K Buy
+17,381
New +$159K ﹤0.01% 2294

Other funds holding SRNE